{
  "guideline": {
    "id": "PA166104987",
    "name": "Annotation of DPWG Guideline for lansoprazole and CYP2C19",
    "source": "DPWG",
    "version": 26,
    "url": "https://www.pharmgkb.org/guidelineAnnotation/PA166104987",
    "relatedChemicals": [
      {
        "id": "PA450180",
        "name": "lansoprazole",
        "symbol": null
      }
    ],
    "relatedGenes": [
      {
        "id": "PA124",
        "name": "cytochrome P450 family 2 subfamily C member 19",
        "symbol": "CYP2C19"
      }
    ],
    "recommendation": true,
    "guidelineGenes": [
      {
        "alleles": [
          {
            "id": 1451417378,
            "_label": "*1",
            "function": {
              "term": "Normal function",
              "termId": "haplotypeTags:1445558335"
            }
          },
          {
            "id": 1451417379,
            "_label": "*2",
            "function": {
              "term": "No function",
              "termId": "haplotypeTags:1445558515"
            }
          },
          {
            "id": 1451417400,
            "_label": "*3",
            "function": {
              "term": "No function",
              "termId": "haplotypeTags:1445558515"
            }
          },
          {
            "id": 1451417401,
            "_label": "*4",
            "function": {
              "term": "No function",
              "termId": "haplotypeTags:1445558515"
            }
          },
          {
            "id": 1451417402,
            "_label": "*5",
            "function": {
              "term": "No function",
              "termId": "haplotypeTags:1445558515"
            }
          },
          {
            "id": 1451417403,
            "_label": "*6",
            "function": {
              "term": "No function",
              "termId": "haplotypeTags:1445558515"
            }
          },
          {
            "id": 1451417404,
            "_label": "*7",
            "function": {
              "term": "No function",
              "termId": "haplotypeTags:1445558515"
            }
          },
          {
            "id": 1451417405,
            "_label": "*8",
            "function": {
              "term": "No function",
              "termId": "haplotypeTags:1445558515"
            }
          },
          {
            "id": 1451417406,
            "_label": "*9",
            "function": {
              "term": "Decreased function",
              "termId": "haplotypeTags:1445558331"
            }
          },
          {
            "id": 1451417407,
            "_label": "*10",
            "function": {
              "term": "Decreased function",
              "termId": "haplotypeTags:1445558331"
            }
          },
          {
            "id": 1451417408,
            "_label": "*17",
            "function": {
              "term": "Increased function",
              "termId": "haplotypeTags:1445558332"
            }
          }
        ],
        "gene": {
          "chr": {
            "id": "PA504",
            "name": "chr10",
            "symbol": null
          },
          "strand": "plus",
          "id": "PA124",
          "name": "cytochrome P450 family 2 subfamily C member 19",
          "symbol": "CYP2C19"
        }
      }
    ]
  },
  "annotationGroups": [
    {
      "id": "PA166240483",
      "name": "NM",
      "strength": {
        "term": "N/A",
        "termId": "guidelineStrength:981501929"
      },
      "rxChangeStatus": {
        "term": "No",
        "termId": "rxChange:1448602495"
      },
      "genePhenotypes": [
        "CYP2C19:Increased function/Normal function",
        "CYP2C19:Normal function/Normal function"
      ],
      "metabolizerStatus": {
        "id": 1451417527,
        "html": "<p>Normal Metabolizer</p>\n"
      },
      "recommendation": {
        "id": 1451417528,
        "html": "<p>The guideline does not provide a recommendation for lansoprazole in normal metabolizers.</p>\n"
      },
      "implications": {
        "id": 1451417526,
        "html": "<p>The guideline does not provide a description of the impact of a normal metabolizer phenotype on lansoprazole.</p>\n"
      },
      "activityScore": null
    },
    {
      "id": "PA166240461",
      "name": "PM",
      "strength": {
        "term": "N/A",
        "termId": "guidelineStrength:981501929"
      },
      "rxChangeStatus": {
        "term": "No",
        "termId": "rxChange:1448602495"
      },
      "genePhenotypes": [
        "CYP2C19:Decreased function/Decreased function",
        "CYP2C19:Decreased function/No function",
        "CYP2C19:No function/No function"
      ],
      "metabolizerStatus": {
        "id": 1451417501,
        "html": "<p>Poor Metabolizer</p>\n"
      },
      "recommendation": {
        "id": 1451417502,
        "html": "<p>The higher plasma concentration of lansoprazole results in an increase in the therapeutic effectiveness, without an increase in the incidence of side effects.</p>\n"
      },
      "implications": {
        "id": 1451417500,
        "html": "<p>NO action is needed for this gene-drug interaction.</p>\n"
      },
      "activityScore": null
    },
    {
      "id": "PA166240481",
      "name": "IM",
      "strength": {
        "term": "N/A",
        "termId": "guidelineStrength:981501929"
      },
      "rxChangeStatus": {
        "term": "No",
        "termId": "rxChange:1448602495"
      },
      "genePhenotypes": [
        "CYP2C19:Decreased function/Increased function",
        "CYP2C19:Decreased function/Normal function",
        "CYP2C19:Increased function/No function",
        "CYP2C19:No function/Normal function"
      ],
      "metabolizerStatus": {
        "id": 1451417521,
        "html": "<p>Intermediate Metabolizer</p>\n"
      },
      "recommendation": {
        "id": 1451417522,
        "html": "<p>The higher plasma concentration of lansoprazole results in an increase in the therapeutic effectiveness, without an increase in the incidence of side effects.</p>\n"
      },
      "implications": {
        "id": 1451417520,
        "html": "<p>NO action is needed for this gene-drug interaction.</p>\n"
      },
      "activityScore": null
    },
    {
      "id": "PA166240482",
      "name": "UM",
      "strength": {
        "term": "N/A",
        "termId": "guidelineStrength:981501929"
      },
      "rxChangeStatus": {
        "term": "Yes",
        "termId": "rxChange:1448602497"
      },
      "genePhenotypes": [
        "CYP2C19:Increased function/Increased function"
      ],
      "metabolizerStatus": {
        "id": 1451838121,
        "html": "<p>Ultrarapid Metabolizer</p>\n"
      },
      "recommendation": {
        "id": 1451838122,
        "html": "<p>For Helicobacter pylori ERADICATION THERAPY: 1. Use a 4-fold higher dose. 2. Advise the patient to contact their doctor if symptoms of dyspepsia persist.\nOTHER INDICATIONS: 1. Be alert to reduced effectiveness. 2. If necessary, use a 4-fold higher dose. 3. Advise the patient to report persisting symptoms of dyspepsia.</p>\n"
      },
      "implications": {
        "id": 1451838120,
        "html": "<p>The genetic variation may reduce lansoprazole plasma concentrations and therefore lansoprazole effectiveness.</p>\n"
      },
      "activityScore": null
    }
  ],
  "citations": [
    {
      "pmid": "21412232",
      "title": "Pharmacogenetics: from bench to byte--an update of guidelines.",
      "authors": [
        "Swen J J",
        "Nijenhuis M",
        "de Boer A",
        "Grandia L",
        "Maitland-van der Zee A H",
        "Mulder H",
        "Rongen G A P J M",
        "van Schaik R H N",
        "Schalekamp T",
        "Touw D J",
        "van der Weide J",
        "Wilffert B",
        "Deneer V H M",
        "Guchelaar H-J"
      ],
      "journal": "Clinical pharmacology and therapeutics",
      "year": 2011
    }
  ],
  "version": "2023-01-05-00-25"
}